Abstract

Background:Rheumatoid arthritis (RA) is more frequent in women (3:1) and affects all aspects of quality of life, including sexual health. The treatment landscape for RA has undergone a transformative shift...

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Sexual Health in Patients with Rheumatoid Arthritis: Experiences, Needs and Communication with Health Care Professionals
Kristina Areskoug Josefsson ... Gunvor Gard
Musculoskeletal Care | VOL. 10
Kristina Areskoug Josefsson, et. al.Kristina Areskoug Josefsson ... Gunvor Gard
06 Jan 2012
Pharmacists' practices and views regarding management of sexual health in patients with cancer.
Alisha Shivji ... Sunita Ghosh
Journal of Oncology Pharmacy Practice | VOL. 29
Alisha Shivji, et. al.Alisha Shivji ... Sunita Ghosh
19 Apr 2022
Sexual dysfunction in women with epilepsy
Cynthia L Harden
Seizure | VOL. 17
Cynthia L HardenCynthia L Harden
04 Feb 2008
Arriving at the diagnosis of female sexual dysfunction
Erin Z Latif ... Michael P Diamond
Fertility and Sterility | VOL. 100
Erin Z Latif, et. al.Erin Z Latif ... Michael P Diamond
04 Sep 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.